M&A will be among the trends that will influence the biotech market in 2024.
Experts in the field believe that the biotech industry is poised for recovery in 2024, and one reason for that would be a favorable climate for M&A activity. A PwC report predicts the M&A deal totals could range from $225 billion to $275 billion. M&A will be among the trends that will influence the biotech market in 2024.